Skip to content

S-Ketamine Rapidly Reverses Synaptic and Vascular Deficits of Hippocampus in Genetic Animal Model of Depression

Maryam Ardalan, Gregers Wegener, Ali H. Rafati, Jens Randel Nyengaard

The International Journal of Neuropsychopharmacology November 2, 2016 DOI: 10.1093/ijnp/pyw098 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Preclinical experimental study in a genetic rat model Peer reviewed
Population Flinders Sensitive Line and Flinders Resistant Line rats
Intervention Ketamine
Dose 15 mg/kg
Duration 24 hours after a single injection
Measures modified forced swim test, global spatial sampling and optical microscopy for microvessel length, serial section electron microscopy with physical disector method for asymmetric synapses
Topics Depression Esketamine Ketamine
Citations 38
Key findings A single ketamine injection (15 mg/kg) in Flinders Sensitive Line rats reduced forced swim test immobility and increased nonperforated and perforated synapses and total microvessel length in hippocampal CA1.stratum radiatum one day later, though shaft synapses did not increase significantly. The authors argue these findings indicate rapid co-regulation of hippocampal vascularization and synaptogenesis after ketamine, with microvascular elongation possibly supporting synaptic plasticity.

Abstract

Background: The neurovascular plasticity of hippocampus is an important theory underlying major depression. Ketamine as a novel glutamatergic antidepressant drug can induce a rapid antidepressant effect within hours. In a mechanistic proof of this concept, we examined whether ketamine leads to an increase in synaptogenesis and vascularization within 24 hours after a single injection in a genetic rat model of depression.

Methods: Flinders Sensitive Line and Flinders Resistant Line rats were given a single intraperitoneal injection of ketamine (15 mg/kg) or saline. One day later, their behavior was evaluated by a modified forced swim test. Microvessel length was evaluated with global spatial sampling and optical microscopy, whereas the number of asymmetric synapses was quantified through serial section electron microscopy by using physical disector method in the CA1.stratum radiatum area of hippocampus.

Results: The immobility time in the forced swim test among Flinders Sensitive Line rats with ketamine treatment was significantly lower compared with Flinders Sensitive Line rats without treatment. The number of nonperforated and perforated synapses was significantly higher in the Flinders Sensitive Line-ketamine vs the Flinders Sensitive Line-vehicle group; however, ketamine did not induce a significant increase in the number of shaft synapses. Additionally, total length of microvessels was significantly increased 1 day after ketamine treatment in Flinders Sensitive Line rats in the hippocampal subregions, including the CA1.stratum radiatum.

Conclusion: Our findings indicate that hippocampal vascularization and synaptogenesis is co-regulated rapidly after ketamine, and microvascular elongation may be a supportive factor for synaptic plasticity and neuronal activity. These findings go hand-in-hand with the behavioral observations, where ketamine acts as a potent antidepressant.

Comparable studies

Other preclinical and animal studies on esketamine for depression, most cited first.

Study Year Design Participants
Low-dose S-ketamine exerts antidepressant-like effects via enhanced hippocampal synaptic plasticity in postpartum depression rats. Rat model of postpartum depression induced by reproductive hormone withdrawal 2022 Animal study
Antidepressant effects of esketamine via the BDNF/AKT/mTOR pathway in mice with postpartum depression and their offspring. Mice with postpartum depression and their offspring 2024 Animal study
Electroconvulsive therapy combined with esketamine improved depression through PI3K/AKT/GLT-1 pathway. Human patients with severe depression and a rat model of depression 2025 Randomized controlled trial and animal study n = 12
S-ketamine Alleviates Neuroinflammation and Attenuates Lipopolysaccharide-Induced Depression Via Targeting SIRT2. Lipopolysaccharide (LPS)-induced mouse model 2025 Animal study with in vitro and in vivo experiments
Esketamine alleviates LPS-induced depression-like behavior by activating Nrf2-mediated anti-inflammatory response in adolescent mice. Adolescent male C57BL/6J mice 2025 Preclinical experimental study

Citations in the library

Cited by 14

and 9 more in the library

Cites 9

and 4 more in the library

Explore topics

By condition and practice